Clinical Trials Browser

Genetic Diseases, Inborn × 90 days × Clear all

Anxiety Disorders, Depression, Hematologic Neoplasms, Genetic Diseases, Inborn

NCT05361811 2026-02-19

Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial

Cardiofaciocutaneous syndrome, Legius syndrome, Neurofibromatosis 1, Noonan Syndrome, Genetic Diseases, Inborn, Costello Syndrome

NCT07408583 2026-02-19

Prenatal Transplantation for Fetuses With Fanconi Anemia

Phase 1/2 Not yet recruiting

12 enrolled

Classical hematology

Bone Marrow Failure Disorders, Congenital Bone Marrow Failure Syndromes, Fanconi Anemia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Anemia, Hypoplastic, Congenital, Genetic Diseases, Inborn, DNA Repair-Deficiency Disorders

NCT03568630 2026-02-02

Blood Markers of Early Pancreas Cancer

Recruiting

1,250 enrolled

Gastrointestinal

Diabetes Mellitus, Type 2, Pancreatic Cyst, Prediabetic State, Genetic Predisposition to Disease, Genetic Diseases, Inborn, Pancreatitis, Chronic

NCT05721326 2026-01-13

Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition

Phase NA Completed

1,330 enrolled

BreastGynecologic

Breast Neoplasms, Neoplastic Syndromes, Hereditary, Ovarian Neoplasms, Genetic Predisposition to Disease, Genetic Diseases, Inborn, Hereditary Breast and Ovarian Cancer Syndrome

NCT06671704 2026-01-08

GC-PRO Intervention

Phase NA Recruiting

994 enrolled

Cardiovascular Diseases, Heart Diseases, Neoplasms, Genetic Diseases, Inborn

Clinical Trials

Evaluation of Association Between Testosterone Levels, Dementia, and Adverse Mental Health Outcomes

Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial

Prenatal Transplantation for Fetuses With Fanconi Anemia

Blood Markers of Early Pancreas Cancer

Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition

GC-PRO Intervention